ANAB Stock Summary and Trading Ideas (Anaptysbio | NASDAQ:ANAB)

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, our PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, our BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Anaptysbio trades on the NASDAQ stock market under the symbol ANAB.

As of May 13, 2024, ANAB stock price climbed to $23.99 with 352,282 million shares trading.

ANAB has a beta of 0.78, meaning it tends to be less sensitive to market movements. ANAB has a correlation of 0.03 to the broad based SPY ETF.

ANAB has a market cap of $655.37 million. This is considered a Small Cap stock.

Last quarter Anaptysbio reported $7 million in Revenue and -$1.64 earnings per share. This beat revenue expectation by $3 million and missed earnings estimates by -$.08.

In the last 3 years, ANAB stock traded as high as $37.89 and as low as $13.36.

The top ETF exchange traded funds that ANAB belongs to (by Net Assets): XBI, VTI, IWM, VXF, VB.

ANAB stock has underperformed the market in the last year with a return of +23.3%, while SPY returned +28.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ANAB shares. However, ANAB has outperformed the market in the last 3 month and 2 week periods, returning +9.0% and +12.6%, while SPY returned +5.8% and +2.1%, respectively. This indicates ANAB has been having a stronger performance recently.

ANAB support price is $22.10 and resistance is $24.72 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ANAB stock will trade within this expected range on the day.